Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-04-30FDA Approved: FENOFIBRATE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' generic fenofibrate under an Original Application (ANDA 209504).
-
CLINICAL_TRIALS trial_result · 2018-04-27Clinical Trial Update: Postprandial Effects of Milk and Milk Constituents [NA]
This clinical trial from Maastricht University Medical Center completed an evaluation of postprandial effects of milk and milk constituents …
-
FDA approval · 2018-04-25FDA Approved: LOPID — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for Lopid (gemfibrozil) submitted by Parke-Davis Div of Pfizer Inc.
-
FDA approval · 2018-04-20FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for fenofibrate from Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2018-04-13FDA Approved: PRAVASTATIN SODIUM — Original Application (Biocon Pharma Inc.)
FDA approved Biocon Pharma's pravastatin sodium as an original ANDA, authorizing a generic version of pravastatin for lowering cholesterol. …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-04-05Clinical Trial Update: Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons [NA]
This study evaluated how reducing saturated fat affects cholesterol and lipoprotein levels in lean and obese adults.
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Cardiovascular Health And Risk Modification in Family Health Teams [Phase 3]
A Phase 3 clinical trial evaluating cardiovascular health and risk modification in family health teams has completed.
-
FDA approval · 2018-03-30FDA Approved: ATORVASTATIN CALCIUM — Original Application (Accord Healthcare Inc.)
FDA approves Accord Healthcare's atorvastatin calcium as an original application (ANDA) for a generic atorvastatin calcium product.
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers [Phase 1]
Phase 1 pharmacokinetic study assessing PK interactions when co-administering metformin sustained-release, rosuvastatin, and JLP-1310 in hea…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers [Phase 1]
Phase 1 study investigating the effect of food on the pharmacokinetics of JLP-1310 in healthy male volunteers has completed, sponsored by Je…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and Rosuvastatin [Phase 1]
Phase 1 study completed to evaluate the pharmacokinetic interaction between metformin and rosuvastatin.
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol [Phase 3]
Phase 3 trial of evacetrapib (LY2484595) in participants with high cholesterol was terminated; results posted in 2018.
-
FDA approval · 2018-03-19FDA Approved: FENOFIBRATE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's fenofibrate generic under an original application (ANDA). This represents the approval of a fen…
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3 [Phase 3]
Phase 3 trial update on achieving goals after using an anti-PCSK9 antibody in statin-intolerant individuals with hyperlipidemia.
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers [Phase 1]
Phase 1 study evaluating potential drug-drug interaction when co-administering Telmisartan/Amlodipine with Atorvastatin in healthy adult vol…
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia [Phase 4]
Phase 4 trial evaluating the safety and efficacy of pitavastatin in patients with impaired fasting glucose (prediabetes) and hyperlipidemia …
-
FDA approval · 2018-02-28FDA Approved: ZOCOR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for ZOCOR (simvastatin) submitted by Organon LLC. The action commonly updates labeling, indications,…
-
FDA approval · 2018-02-09FDA Approved: FENOFIBRATE — Original Application (AvKARE)
FDA approved AvKARE's generic fenofibrate under an Original Application (ANDA 209951).
-
FDA approval · 2018-02-01FDA Approved: NIACIN — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original ANDA for NIACIN, a generic niacin product intended to treat dyslipidemia and related lipid …
-
FDA approval · 2017-12-22FDA Approved: EZETIMIBE AND SIMVASTATIN — Original Application (Ascend Laboratories, LLC)
FDA approved an original application for a fixed-dose combination of ezetimibe and simvastatin by Ascend Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2017-12-19Clinical Trial Update: Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia [Phase 3]
Phase 3 trial update on bococizumab with an autoinjector in hyperlipidemia; study completed with results posted in 2017.
-
FDA approval · 2017-12-19FDA Approved: FENOFIBRATE — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' original application for fenofibrate, authorizing the marketing of a generic fenofibrate product.
-
CLINICAL_TRIALS trial_result · 2017-12-14Clinical Trial Update: Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins [Phase 3]
A Phase 3 randomized trial evaluating bococizumab in statin-intolerant patients with hyperlipidemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Effects of Psyllium on Niacin Tolerability [Phase 4]
Phase 4 clinical trial completed to evaluate whether psyllium affects tolerability of niacin in individuals with lipid disorders.
-
CLINICAL_TRIALS withdrawal · 2017-12-02Clinical Trial Update: Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects [Phase 3]
Pfizer has withdrawn the Phase 3 trial evaluating bococizumab for lipid lowering in Asian subjects with primary hyperlipidemia or mixed dysl…